Aclarion, Inc., a Delaware-incorporated company, has reported a series of financial transactions involving unsecured non-convertible note financing with accredited investors. Initially, on May 16, 2023, Aclarion received $1,250,000 from the first tranche of this financing. Subsequent tranches closed on September 1, 2023, and November 1, 2023, with the company receiving an additional $750,000 and $250,000, respectively. On January 22, 2024, Aclarion entered into an exchange agreement with these investors to convert the principal and accrued interest on the notes into common stock. Between January 23 and January 26, 2024, additional exchange agreements were made, resulting in the issuance of 500,000 shares of common stock to cover approximately $1,185,226 of the notes. This increased Aclarion's total outstanding shares to 1,791,375 as of January 26, 2024. While the company has expressed interest in future exchanges, no definitive agreements are currently in place. The shares issued in these exchanges are intended to be exempt from registration under the Securities Act of 1933, as amended, according to the exemptions under Section 3(a)(9) and Section 4(a)(2), and Regulation D.

Aclarion, Inc., a Delaware-incorporated company, has reported a series of financial transactions involving unsecured non-convertible note financing with accredited investors. Initially, on May 16, 2023, Aclarion received $1,250,000 from the first tranche of this financing. Subsequent tranches closed on September 1, 2023, and November 1, 2023, with the company receiving an additional $750,000 and $250,000, respectively. On January 22, 2024, Aclarion entered into an exchange agreement with these investors to convert the principal and accrued interest on the notes into common stock. Between January 23 and January 26, 2024, additional exchange agreements were made, resulting in the issuance of 500,000 shares of common stock to cover approximately $1,185,226 of the notes. This increased Aclarion's total outstanding shares to 1,791,375 as of January 26, 2024. While the company has expressed interest in future exchanges, no definitive agreements are currently in place. The shares issued in these exchanges are intended to be exempt from registration under the Securities Act of 1933, as amended, according to the exemptions under Section 3(a)(9) and Section 4(a)(2), and Regulation D.